Hassan Fred
SEC CIK 1110744 · EDGAR
BoughtSold
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
| 16 | Hassan Fred | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 18:05 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Hassan Fred | Dir | A - Grant | $0.00 | +3,990 | 29.9K | +15% | $0 |
| D | 2026-03-16 | 2026-03-13 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | M - OptEx | — | +71.8K | 1.24M | +6% | — |
| D | 2026-03-12 | 2026-03-10 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | A - Grant | $3.51 | +17.9K | 1.17M | +2% | +$63.0K |
| D | 2025-10-30 | 2025-10-28 | COCP | Cocrystal Pharma, Inc. | Hassan Fred | Dir | A - Grant | $1.39 | +359.7K | 1.38M | +35% | +$500.0K |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | Hassan Fred | Dir | A - Grant | $0.00 | +6,589 | 25.9K | +34% | $0 |
| D | 2025-03-17 | 2025-03-14 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | M - OptEx | — | +87.4K | 1.15M | +8% | — |
| D | 2025-03-17 | 2025-03-13 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | A - Grant | $1.74 | +36.2K | 1.07M | +4% | +$63.0K |
| 2024-10-11 | 2024-10-09 | COCP | Cocrystal Pharma, Inc. | Hassan Fred | Dir | A - Grant | — | +8,067 | 1.02M | +0.8% | — | |
| D | 2024-03-18 | 2024-03-14 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | A - Grant | $1.43 | +44.1K | 1.03M | +4% | +$63.0K |
| D | 2024-03-12 | 2024-03-09 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | M - OptEx | — | +106.8K | 985.8K | +12% | — |
| 2023-08-16 | 2023-08-14 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | P - Purchase | $1.75 | +570.3K | 878.9K | +185% | +$998.1K | |
| D | 2023-03-13 | 2023-03-09 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | A - Grant | $1.17 | +48.3K | 308.6K | +19% | +$56.5K |
| D | 2023-02-24 | 2023-02-22 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | M - OptEx | — | +61.6K | 260.3K | +31% | — |
| D | 2022-03-29 | 2022-03-25 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | M - OptEx | — | +16.2K | 198.7K | +9% | — |
| D | 2022-02-24 | 2022-02-22 | PGEN | PRECIGEN, INC. | Hassan Fred | Dir | A - Grant | $2.03 | +27.8K | 182.5K | +18% | +$56.5K |
| 2022-01-03 | 2021-12-29 | BBIO | BridgeBio Pharma, Inc. | Hassan Fred | Dir | P - Purchase | $14.17 | +19.3K | 19.3K | New | +$273.5K |
Purchase Sale Sale after option exercise All abbreviations